2000 RA patients monitored to see how treatments really work in japan
NCT ID NCT02737449
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This study follows 2,000 adults with rheumatoid arthritis in Japan to compare the real-world safety and effectiveness of common treatments like DMARDs and JAK inhibitors. Researchers track side effects, joint pain, and disease activity over time. Participants are already prescribed these medications as part of their normal care. The goal is to learn which treatments work best and are safest for Japanese patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.